Trial · NCT03245762
Intranasal Oxytocin for Infants With Prader-Willi Syndrome
NCT03245762, Phase 1, Phase 2, Completed, University of Florida; results first posted 2019-06-25
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Intranasal Oxytocin for Infants With Prader-Willi Syndrome. Trials, record NCT03245762. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03245762
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Intranasal Oxytocin for Infants With Prader-Willi Syndrome
- NCT number
- NCT03245762
- Status
- Completed
- Phases
- Phase 1, Phase 2
- Enrollment
- 15 participants, actual
- Lead sponsor
- University of Florida
- Conditions
- Prader-Willi Syndrome
- Interventions
- Oxytocin, Placebo
- First posted
- 2017-08-10
- Last updated
- 2020-03-26
- Results first posted
- 2019-06-25
- Limitations and caveats
- Short study with small number of participants
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Suck and Swallow Competency in Infants/Children With PWS Who Are in Nutritional Phase 1a | baseline to day 5 | Swallow study Overall improvement |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Suck and Swallow Competency in Infants/Children With PWS Who Are in Nutritional Phase 1a | baseline to day 5 | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group6
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Suck and Swallow Competency in Infants/Children With PWS Who Are in Nutritional Phase 1a | Intranasal Oxytocin | Improved Competency | 8 | Participants | |
| Suck and Swallow Competency in Infants/Children With PWS Who Are in Nutritional Phase 1a | IN-placebo | Improved Competency | 4 | Participants | |
| Suck and Swallow Competency in Infants/Children With PWS Who Are in Nutritional Phase 1a | Intranasal Oxytocin | No Change in Competency' | 1 | Participants | |
| Suck and Swallow Competency in Infants/Children With PWS Who Are in Nutritional Phase 1a | IN-placebo | No Change in Competency' | 1 | Participants | |
| Suck and Swallow Competency in Infants/Children With PWS Who Are in Nutritional Phase 1a | Intranasal Oxytocin | Worsened Competency | 1 | Participants | |
| Suck and Swallow Competency in Infants/Children With PWS Who Are in Nutritional Phase 1a | IN-placebo | Worsened Competency | 0 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Intranasal Oxytocin | 10 | |
| Overall Study | STARTED | IN-placebo | 5 | |
| Overall Study | COMPLETED | Intranasal Oxytocin | 10 | |
| Overall Study | COMPLETED | IN-placebo | 5 | |
| Overall Study | NOT COMPLETED | Intranasal Oxytocin | 0 | |
| Overall Study | NOT COMPLETED | IN-placebo | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Intranasal Oxytocin | 0 | 10 |
| Total, all-cause mortality | IN-placebo | 0 | 5 |
| Total, other adverse events | Intranasal Oxytocin | 0 | 10 |
| Total, other adverse events | IN-placebo | 0 | 5 |
| Total, serious adverse events | Intranasal Oxytocin | 0 | 10 |
| Total, serious adverse events | IN-placebo | 0 | 5 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Intranasal Oxytocin vs IN-placebo: deaths from any cause | Trial comparisons |
| Intranasal Oxytocin vs IN-placebo: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03245762
GET https://conductscience.org/api/trials/v1/NCT03245762/registered